ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,982, issued on July 15, was assigned to Marengo Therapeutics Inc. (Cambridge, Mass.).
"Multifunctional molecules that bind to T cell related cancer cells and uses thereof" was invented by Andreas Loew (Boston), Nidhi Malhotra (Boston), Madan Katragadda (Acton, Mass.), Seng-Lai Tan (Sudbury, Mass.), Jonathan Hsu (Waltham, Mass.), Brian Edward Vash (Cambridge, Mass.), Stephanie J. Maiocco (Arlington, Mass.), Peter Marek (Hudson, Mass.) and Gurkan Guntas (Newton, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Multifunctional molecules that include i) an antigen binding domain that binds to a T cell receptor beta chain constant domain 1 or T cell ...